These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension. Fujiwara M; Yagi H; Matsuoka R; Akimoto K; Furutani M; Imamura S; Uehara R; Nakayama T; Takao A; Nakazawa M; Saji T Circ J; 2008 Jan; 72(1):127-33. PubMed ID: 18159113 [TBL] [Abstract][Full Text] [Related]
23. Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension. Nasim MT; Ghouri A; Patel B; James V; Rudarakanchana N; Morrell NW; Trembath RC Hum Mol Genet; 2008 Jun; 17(11):1683-94. PubMed ID: 18321866 [TBL] [Abstract][Full Text] [Related]
24. Pulmonary arterial hypertension and portal hypertension in a patient with hereditary hemorrhagic telangiectasia. Pousada G; Baloira A; Valverde D Med Clin (Barc); 2015 Mar; 144(6):261-4. PubMed ID: 25543221 [TBL] [Abstract][Full Text] [Related]
26. [A gene for primary pulmonary artery hypertension]. Humbert M; Soubrier F; Simonneau G Rev Mal Respir; 2001 Oct; 18(5):473-8. PubMed ID: 11887763 [No Abstract] [Full Text] [Related]
27. Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension. Rosenzweig EB; Morse JH; Knowles JA; Chada KK; Khan AM; Roberts KE; McElroy JJ; Juskiw NK; Mallory NC; Rich S; Diamond B; Barst RJ J Heart Lung Transplant; 2008 Jun; 27(6):668-74. PubMed ID: 18503968 [TBL] [Abstract][Full Text] [Related]
28. Identification of a novel mutation in the gene for bone morphogenetic protein receptor II in an Israeli patient with familial primary pulmonary hypertension. Cahn A; Meiner V; Leitersdorf E; Berkman N Isr Med Assoc J; 2004 Mar; 6(3):156-9. PubMed ID: 15055271 [TBL] [Abstract][Full Text] [Related]
29. Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. Newman JH; Wheeler L; Lane KB; Loyd E; Gaddipati R; Phillips JA; Loyd JE N Engl J Med; 2001 Aug; 345(5):319-24. PubMed ID: 11484688 [TBL] [Abstract][Full Text] [Related]
31. Genetics and genomics of pulmonary arterial hypertension. Soubrier F; Chung WK; Machado R; Grünig E; Aldred M; Geraci M; Loyd JE; Elliott CG; Trembath RC; Newman JH; Humbert M J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D13-21. PubMed ID: 24355637 [TBL] [Abstract][Full Text] [Related]
32. Lack of circulating autoantibodies to bone morphogenetic protein receptor-II or activin receptor-like kinase 1 in mixed connective tissue disease patients with pulmonary arterial hypertension. Satoh T; Kimura K; Okano Y; Hirakata M; Kawakami Y; Kuwana M Rheumatology (Oxford); 2005 Feb; 44(2):192-6. PubMed ID: 15509626 [TBL] [Abstract][Full Text] [Related]
33. Pulmonary arterial hypertension in hereditary hemorrhagic telangiectasia associated with ACVRL1 mutation: a case report. Walsh LJ; Collins C; Ibrahim H; Kerins DM; Brady AP; O Connor TM J Med Case Rep; 2022 Mar; 16(1):99. PubMed ID: 35232468 [TBL] [Abstract][Full Text] [Related]
34. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension. Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463 [TBL] [Abstract][Full Text] [Related]
35. Genetics and mediators in pulmonary arterial hypertension. Austin ED; Loyd JE Clin Chest Med; 2007 Mar; 28(1):43-57, vii-viii. PubMed ID: 17338927 [TBL] [Abstract][Full Text] [Related]
36. Insights into the genetic and molecular basis of primary pulmonary hypertension. Trembath RC; Harrison R Pediatr Res; 2003 Jun; 53(6):883-8. PubMed ID: 12621102 [TBL] [Abstract][Full Text] [Related]